{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening *6170*

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Cognate Code 6170

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the use of cell-free DNA prenatal testing.
  2. Describe the similarities between placental development and maternal tumor growth.
  3. Discuss the clinical implications for the patient of the finding of multiple aneuploidies or a single autosomal monosomy during cell-free DNA screening.
  4. Provide pretest and posttest genetic counseling.

Disclosures

Financial Disclosure: Mary E. Norton reports that her institution received research support from Natera and she has been a consultant for Invitae. The remaining authors did not report any potential conflicts of interest.

Price: $25.00

Credits:

  • ACOG 2.0 CME

The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.

Planner
Professions: Physician
Test Code: ONG0722
Published: June 9, 2022
Expires: 7/31/2025
Sources: Obstetrics & Gynecology
Required Passing Score: 7/10 (70%)
Authors: Britton D. Rink, MD, MS, Blair K. Stevens, MS, CGC, and Mary E. Norton, MD
Categories: Gynecological , Management , Obstetrical , Women's Health
Specialties: OB/GYN
Topics: Cell-Free DNA Screening , Prenatal Testing